Showing Funds Performance since Sep 07, 2020

| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | 4.86 | 1.33 | 23.39 |
| 6M | 2.49 | 1.78 | 95.07 |
| 1Y | 11.88 | 5.76 | 265.59 |
| 3Y | 0.00 | 14.02 | 335.86 |
HDFC Pharma and Healthcare Fund Growth managed by HDFC Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹1,977 Crore. The fund benchmarks its performance against the BSE Healthcare while maintaining an expense ratio of 2.1. Under the expert guidance of Nikhil Mathur ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Mr. Nikhil Mathur holds PGDM - IMT, Ghaziabad, B.E. (Civil) - PEC, Chandigarh, CFA (USA) level 3 cleared. He has over 7 years of experience in equity research and 2 years in financial advisory.
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| This FundSBI Quant Fund Growth | 0 | 2971.51 CR | 2.01 |
| This FundAxis India Manufacturing Fund Growth | 0 | 4681.4 CR | 1.84 |
| This FundHDFC Pharma and Healthcare Fund Growth | 0 | 1976.86 CR | 2.1 |
| This FundICICI Prudential PSU Equity Fund Growth | 0 | 1798.21 CR | 2.1 |
| This FundNippon India Taiwan Equity Fund Growth | 3 | 599.16 CR | 2.36 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundSBI Quant Fund Growth | 7.6602 | 0 |
| This FundAxis India Manufacturing Fund Growth | 14.7476 | 0 |
| This FundHDFC Pharma and Healthcare Fund Growth | 11.8832 | 0 |
| This FundICICI Prudential PSU Equity Fund Growth | 10.7949 | 112.0188 |
| This FundNippon India Taiwan Equity Fund Growth | 260.5585 | 318.1066 |